Core Scientific (CORZ) Revenue (2021 - 2026)
Core Scientific has reported Revenue over the past 6 years, most recently at $115.2 million for Q1 2026.
- Quarterly results put Revenue at $115.2 million for Q1 2026, up 44.92% from a year ago — trailing twelve months through Mar 2026 was $354.7 million (down 13.67% YoY), and the annual figure for FY2025 was $319.0 million, down 37.53%.
- Revenue reached $115.2 million in Q1 2026 per CORZ's latest filing, up from $79.8 million in the prior quarter.
- Across five years, Revenue topped out at $192.5 million in Q1 2022 and bottomed at $78.6 million in Q2 2025.
- Median Revenue over the past 5 years was $120.7 million (2023), compared with a mean of $122.8 million.
- Peak annual rise in Revenue hit 254.9% in 2022, while the deepest fall reached 59.82% in 2022.
- Over 5 years, Revenue stood at $121.2 million in 2022, then increased by 17.05% to $141.9 million in 2023, then tumbled by 33.12% to $94.9 million in 2024, then dropped by 15.97% to $79.8 million in 2025, then surged by 44.48% to $115.2 million in 2026.
- Business Quant data shows Revenue for CORZ at $115.2 million in Q1 2026, $79.8 million in Q4 2025, and $81.1 million in Q3 2025.